| Apr-23-20 11:00PM | J&J strikes deal with Emergent BioSolutions on coronavirus vaccine manufacturing Reuters |
| 06:51PM | Johnson & Johnson Announces Collaboration to Expand Manufacturing Capabilities For its COVID-19 Vaccine Candidate in Support of the Company's Goal to Supply More Than One Billion Vaccine Doses Globally PR Newswire |
| 02:22PM | Johnson & Johnson: Full Recovery in Sight GuruFocus.com |
| 08:00AM | Is ISRG Stock A Buy After Coronavirus Slammed Quarterly Growth? Investor's Business Daily |
| 07:53AM | The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt Benzinga |
| Apr-22-20 01:20PM | Hedge Funds This Stock Pick Debunked Naysayers Insider Monkey |
| 12:14PM | Johnson & Johnson Lifted to Buy as Outperformer in `Difficult Times' TheStreet.com |
| 08:00AM | These 'Healthy' Stocks Tip The Coronavirus Market In Your Favor Investor's Business Daily |
| 07:46AM | AbbVie Gets FDA Nod for Imbruvica+Rituxan in First-Line CLL Zacks |
| Apr-21-20 03:36PM | U.S. replaces director of agency overseeing COVID-19 vaccines, drugs Reuters |
| Apr-20-20 06:57PM | Video- Back to Basics: Dividend Investing GuruFocus.com |
| 06:11PM | Market Recap: Monday, April 20 Yahoo Finance Video |
| 03:39PM | Johnson & Johnson's Diversified Business Serves It Well in Uncertain Times GuruFocus.com |
| 02:30PM | 4 Top Sectors of Last Week & Their Winning ETFs Zacks |
| 09:15AM | Back-to-Back Weekly Gains as Stocks Continue to Recover Zacks |
| 08:00AM | 5 Best Leveraged ETF Areas of Last Week Zacks |
| 06:22AM | RPT-BUZZ-U.S. stocks weekly: Roadmap Reuters |
| 06:00AM | RPT-Drug trial specialists see coronavirus-fueled spike in demand for virtual services Reuters |
| Apr-19-20 02:44PM | Barron's Picks And Pans: Dropbox, Ford, Johnson & Johnson, Teladoc And More Benzinga |
| Apr-18-20 10:44AM | Results: Johnson & Johnson Exceeded Expectations And The Consensus Has Updated Its Estimates Simply Wall St. |
| Apr-17-20 07:52PM | A Covid-19 Vaccine Could Take Longer Than Investors Expect. Heres Why. Barrons.com |
| 02:52PM | J&J and P&G, in Raising Their Dividends, Buck the Broader Trend Barrons.com |
| 12:54PM | Q1 Earnings Scorecard and Analyst Reports for Netflix, Costco & Others Zacks |
| 10:43AM | U.S., European health agencies to partner drugmakers in coronavirus fight Reuters |
| 10:30AM | Senator Ted Cruz on Coronavirus Testing and Reopening the U.S. Economy Yahoo Finance Video |
| 10:08AM | Pharma Stock Roundup: JNJ's Q1 Earnings, Coronavirus Product Development Efforts Zacks |
| 08:37AM | Institutional investors tell Big Pharma to cooperate on coronavirus Reuters |
| 08:04AM | Drug trial specialists see coronavirus-fueled spike in demand for virtual services Reuters |
| 08:00AM | Is ISRG Stock A Buy After Coronavirus Slammed Quarterly Growth? Investor's Business Daily |
| 06:22AM | Johnson & Johnson execs offer upbeat view of second-half recovery from COVID-19 pandemic MarketWatch |
| Apr-16-20 06:50PM | 5 Pharmaceutical Companies to Consider as Coronavirus Vaccine Race Heats Up GuruFocus.com |
| 04:38PM | These Highly Rated Medical Stocks Broke Out Under Coronavirus Limelight Investor's Business Daily |
| 03:02PM | Is Abbott A Buy After Launching Not One But Three Coronavirus Tests? Investor's Business Daily |
| 10:19AM | Why Johnson & Johnson Inspires Cramer's Bullishness On Disney, Visa, Mastercard Benzinga |
| 08:30AM | A Crisis Shows the Value of Big Government and Big Business Bloomberg |
| 06:35AM | These Mass. companies are developing COVID-19 treatments and tests American City Business Journals |
| 06:28AM | Moderna agrees deal with US government on scaling up testing for vaccine Financial Times |
| Apr-15-20 10:55PM | Edited Transcript of JNJ earnings conference call or presentation 14-Apr-20 12:30pm GMT Thomson Reuters StreetEvents |
| 05:01PM | Costco bucks dividend suspension trend with near 8% raise Reuters |
| 10:24AM | Pharma Q1 Earnings Begin With J&J's Report: 3 Stocks to Buy Zacks |
| 10:15AM | JNJ Beats, Cuts View on Coronavirus: Healthcare ETFs in Focus Zacks |
| 09:54AM | Dow sheds nearly 500 points as stocks retreat as coronavirus hits earnings, economic data MarketWatch |
| 08:26AM | Pharma Stocks Rally on Sanofi, GSK Coronavirus Vaccine Tie-Up Zacks |
| 07:00AM | REFILE-U.S. companies walk legal tightrope as earnings season kicks off Reuters |
| 02:44AM | Asian stocks weak after IMF says global economy will shrink MarketWatch |
| Apr-14-20 07:07PM | Stock Market Today With Jim Cramer: Johnson & Johnson TheStreet.com |
| 05:04PM | Johnson & Johnson -- Moody's: Coronavirus will temporarily pressure J&J's earnings Moody's |
| 04:49PM | U.S. stocks close higher as states weigh reopening economy, earnings season kicks off MarketWatch |
| 04:36PM | What Does J&J's Trimmed 2020 Outlook Mean For The Medical Segment? Investor's Business Daily |
| 04:26PM | The Dow Is Rising Because Earnings Were Better Than Feared. Tesla Is Jumping Again. Barrons.com |
| 04:25PM | Johnson & Johnson's 1st-Quarter Earnings and Revenue Edge Past Projections GuruFocus.com |
| 03:02PM | Apple Inc., Johnson & Johnson share gains contribute to Dow's nearly 500-point surge MarketWatch |
| 02:08PM | These 3 Earnings Reports Illustrate What We Are Likely to See This Season TheStreet.com |
| 12:57PM | Dow's 550-point surge highlighted by gains for shares of Home Depot, Apple Inc. MarketWatch |
| 12:30PM | How to Trade Johnson & Johnson Stock After the Report TheStreet.com |
| 12:24PM | Tylenol, Zyrtec sales boost J&J's profit Reuters Videos |
| 12:16PM | Dow Jones Up 500 Points As Coronavirus Slows; Amazon, Netflix Soar On Nasdaq Investor's Business Daily |
| 12:14PM | Dow Rises as Earnings Season Begins and Coronavirus Cases Seen Easing TheStreet.com |
| 11:56AM | J&J Buoyed by Tylenol, Branded Drugs While Devices Struggle Bloomberg |
| 11:56AM | Home Depot, Johnson & Johnson share gains contribute to Dow's 400-point rally MarketWatch |
| 11:43AM | Is JNJ Stock A Buy After CEO Reiterates Bullish View For Covid Vaccine? Investor's Business Daily |
| 10:55AM | Johnson & Johnson, Apple Inc. share gains lead Dow's nearly 475-point surge MarketWatch |
| 10:50AM | Why these internet stocks can ride out a pandemic and rough earnings season MarketWatch |
| 10:48AM | GlaxoSmithKline and Sanofi Announce Joint Coronavirus Vaccine Program Barrons.com |
| 10:16AM | Major Banks Report Q1 Earnings Zacks |
| 10:06AM | Johnson & Johnson's Price Strength Is Ripping the Band-Aid Off This Rally TheStreet.com |
| 09:57AM | Dow Jones Today, Stocks Follow Nasdaq's Bullish Signal; Tesla, Roku Rally: J&J, JPMorgan Rise On Earnings Investor's Business Daily |
| 09:45AM | Dow surges 550 points on gains in Walgreens Boots, Dow Inc. stocks MarketWatch |
| 09:42AM | Johnson & Johnson Turns in Decent Results -- But That's Not Why I'm in the Stock TheStreet.com |
| 09:42AM | Johnson & Johnson Tops Q1 Earnings Forecast; Lowers 2020 Outlook on Coronavius Impact TheStreet.com |
| 09:41AM | Johnson & Johnson Announces Q1 Earnings Beat, Increases Dividend SmarterAnalyst |
| 09:28AM | J&J (JNJ) Beats on Q1 Earnings, Cuts View on Coronavirus Impact Zacks |
| 09:16AM | All 30 Dow stocks rise premarket as earnings get off to upbeat start MarketWatch |
| 08:53AM | J&J lifts dividend but cuts 2020 guidance on coronavirus uncertainty Financial Times |
| 07:55AM | Johnson & Johnson (JNJ) Q1 Earnings and Revenues Surpass Estimates Zacks |
| 07:39AM | US STOCKS-China data lifts futures as JPMorgan, J&J kick off earnings Reuters |
| 06:50AM | J&J beats profit estimates but coronavirus fuels forecast cut Reuters |
| 06:44AM | Johnson & Johnson's stock surges after earnings beat, raised dividend MarketWatch |
| 06:43AM | Johnson & Johnson cuts 2020 profit forecast on coronavirus uncertainty Reuters |
| 06:33AM | Johnson & Johnson board approves quarterly dividend increase of 6.3% to $1.01 a share MarketWatch |
| 06:31AM | Johnson & Johnson Reports 2020 First-Quarter Results PR Newswire |
| 06:30AM | Johnson & Johnson to Host Earnings Call ACCESSWIRE |
| 06:30AM | Johnson & Johnson Announces Dividend Increase of 6.3% PR Newswire |
| 02:34AM | J&J Lifts Dividend After Q1; Full-Year Outlook Cut Investing.com |
| 02:19AM | Top 5 Things to Know in the Market on Tuesday, April 14th Investing.com |
| Apr-13-20 04:58PM | Adesto Technologies: A Solid Internet of Things Play GuruFocus.com |
| 03:34PM | Johnson & Johnson has coronavirus vaccine candidate in works, but medical devices are likely to take a hit MarketWatch |
| 02:30PM | Trading Johnson & Johnson Earnings - Here Are the Must-Know Levels TheStreet.com |
| 12:01PM | Will J&J's Pharma Unit Perform Above Market to Drive Q1 Result? Zacks |
| 11:35AM | U.S. Stocks To Watch This Week FX Empire |
| 10:16AM | Earnings Reports for the Week of April 13-17 (JNJ, JPM, KSU) Kiplinger |
| 09:56AM | Johnson & Johnson Stuck in Neutral Ahead of Earnings Investopedia |
| 09:38AM | Q1 Earnings in Focus Zacks |
| 06:30AM | Johnson & Johnson Reports Earnings Tomorrow. Heres What to Expect. Barrons.com |
| Apr-12-20 06:41PM | This Trio of Strong Performers Is Predicted to Outperform GuruFocus.com |
| Apr-11-20 01:08AM | Johnson & Johnson abandons deal for Takeda's TachoSil surgical patch Reuters |
| Apr-10-20 02:23PM | Johnson & Johnson abandons deal for Takeda's TachoSil surgical patch Reuters |
| 12:13PM | Johnson & Johnson abandons deal for Takeda's TachoSil surgical patch, FTC says Reuters |
| 06:00AM | Two Long-Term Values in Drug Stocks MoneyShow |
| Apr-09-20 03:06PM | Warren Buffettrsquo;s 11 Best Stocks of the Bear Market Kiplinger |
